Thursday, January 27th, 2022 at 8:00 am - 5:00 pm
Speakers: Dr Michelle Hui, Consultant Rheumatologist (UHDB) and Dr Antonia Ugur, Consultant Endocrinologist (UHDB)
- Identify key updates since the last JAPC osteoporosis guidelines and rationale behind these changes
- Explain reasons for and against the use of denosumab in light of emerging evidence
- Outline reasons for referral to the osteoporosis service in secondary care
- Provide an update regarding treatment breaks and the evidence behind these
Register in advance for this meeting:
After registering, you will receive a confirmation email containing information about joining the meeting.
Sponsored by Chiesi Ltd
A list of attendee names will be sent to sponsors.